CurveBeam Connect: The Impact of COVID-19 on Orthopedic Care

 

Dr. Francois Lintz, an orthopedic foot and ankle senior consultant at UCP Toulouse in France, joined Voice of B2B Daniel Litwin to dive into the impact of the COVID-19 pandemic on the French medical community and the world of orthopedics.

In France, the impact of the disease has been felt most regionally around Paris and Alsace, with measures including additional participation of doctors outside infectious disease specialties, the transfer of patients to other areas of the country, and more taking place.

Like many areas of healthcare, orthopedic treatment and surgery have taken a backseat to frontline efforts to fight back against the spread of the novel coronavirus.

However, this hasn’t coincided with a shortage of care – in fact, Lintz said, there’s less need for orthopedic procedures during this time.

“As for orthopedic surgeons like myself, most of us were prepared to go to war with the virus if it came to that,” he said. “But, in fact, because of confinement, people actually injure themselves less. They drive less, they do less sports – so we have fewer injuries, and hospitals have been able to cope with the level of trauma and injuries.”

Moving forward, the country, like the rest of the world, is looking for ways to get back to a new normal that will include a return to regular office visits, elective procedures and more.

For the latest thought leadership, news and event coverage across B2B, be sure to check out our industry pages.

Recent Episodes

In this episode of Care Anywhere: The Global Health Workforce Podcast, host Lea Sims welcomes Syl Trepanier, DNP, RN, Chief Nursing Officer for Providence Health and member of the TruMerit Board of Trustees. With responsibility for representing more than 36,000 nurses across a multi-state health system, Syl shares his personal journey from caregiving as…

The accelerator model is undergoing a transformation, and at the center of this change is HealthTech Arkansas, a powerful program that’s redefining the traditional approach by guaranteeing clinical pilots for healthcare startups. As the healthcare system faces a mounting burden from chronic disease (cardiovascular-related costs alone are projected to reach a staggering $1.8 trillion…

Michael Rothman explores the complexities of sepsis identification and management, highlighting the challenges posed by varying definitions and clinical pathways. He discusses the ineffectiveness of current sepsis screening protocols, which often yield high false-positive rates and fail to reduce mortality meaningfully. The episode concludes by questioning the focus on sepsis-specific initiatives and suggesting that more…